Champions Oncology, based in Baltimore, Maryland, develops technology solutions for personalized oncology drug use and employs 230 staff. Its TumorGraft Technology Platform and Lumin Bioinformatics support pharmaceutical and biotechnology companies in drug discovery.
Champions Oncology (CSBR) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Champions Oncology's actual EPS was $0.05, beating the estimate of $0.01 per share, resulting in a 390.20% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.